Fluphenazine, Serum or Plasma

CPT: 80342
Print Share


  • Prolixin®

Expected Turnaround Time

3 - 4 days

Related Documents

Specimen Requirements


Serum or plasma


2 mL

Minimum Volume

1 mL


Red-top tube, lavender-top (EDTA) tube, or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.


Transfer serum or plasma to a transport tube with plastic stopper within 45 minutes of collection.

Storage Instructions

Room temperature

Stability Requirements



Room temperature

14 days


14 days


14 days

Freeze/thaw cycles

Stable x3

Causes for Rejection

Gel-barrier tube

Test Details


Fluphenazine is a phenothiazine derivative (piperazine) used in the treatment of psychotic disorders. Its dose in milligrams equivalent to 100 mg of chlorpromazine is 0.6−1.2 mg. A statistical evaluation1 of clinical studies found the near maximal effective dose of oral fluphenazine to be <6.9 mg/day. For the decanoate, the near-maximal effective dose was 25 mg/two weeks. As a high potency antipsychotic, it may have a high potential for causing extrapyramidal side effects. This would be in addition to the usual adverse effects of antipsychotic drugs (neurologic, anticholinergic, hypotension). Elderly patients should be observed for these occurrences. The half-life of fluphenazine is formulation-dependent. (The decanoate is 5 to 12 days; the hydrochloride 12 to 60 hours.) Fluphenazine is also used to alleviate pain and in childhood development disorders.


This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.


Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

Reference Interval

Therapeutic: 1.0−10.0 ng/mL

Additional Information

Time to maximum blood concentration after intramuscular injection of fluphenazine enanthate was two to four days, and the plasma half-life was 3.6 and 3.7 days in two patients compared to two to four hours and about 12 hours, respectively, for fluphenazine hydrochloride. Time to maximum blood concentration after intramuscular injection of the decanoate salt was 12 to 24 hours, and plasma half-life was 6.8 and 9.6 days in two patients.


1. Davis JM, Chen N. Dose response and dose equivalence of antipsychotics. J Clin Psychopharm. 2004 Apr; 24(2):192-208. 15206667


American Medical Association, Division of Drugs and Toxicology. Drug Evaluations Subscription. Chicago, Ill: AMA, Winter 1992.
Hiemke C, Baumann P, Bergemann N, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2011. Pharmacopsychiatry. 2011 Sep; 44(6):195-235. 22053351


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
706887 Fluphenazine (Prolixin(R)), S 3650-9 706887 Fluphenazine (Prolixin(R)), S ng/mL 3650-9

For Providers

Please login to order a test.


© 2019  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf